A young adult patient with Li-Fraumeni syndrome-associated glioblastoma: Case discussion and literature review

Glioma Pub Date : 2020-04-01 DOI:10.4103/glioma.glioma_17_20
Xiao-Yu Wu, S. Tian, Biling Liang, Qunying Yang, H. Ng, Shao‐xiong Wu, Q. Chang, Zhongping Chen
{"title":"A young adult patient with Li-Fraumeni syndrome-associated glioblastoma: Case discussion and literature review","authors":"Xiao-Yu Wu, S. Tian, Biling Liang, Qunying Yang, H. Ng, Shao‐xiong Wu, Q. Chang, Zhongping Chen","doi":"10.4103/glioma.glioma_17_20","DOIUrl":null,"url":null,"abstract":"Li-Fraumeni syndrome is an autosomal dominant cancer predisposition syndrome caused by germ line alterations in the tumor suppressor gene TP53, with an incidence of 1 in 5000–1 in 20,000. Li-Fraumeni syndrome is associated with numerous malignancies, including astrocytoma. Here, we report the case of a female patient diagnosed with glioblastoma in the right temporal lobe at the age of 22 years. She was treated with surgery followed by radiation and chemotherapy and achieved a complete response. Not surprisingly, the patient relapsed 7 years later and underwent a second surgery and radiation concurrent with temozolomide followed by chemotherapy with various agents. The patient currently remains tumor-free. Genetic testing revealed that the tumor contained a germ line mutation of TP53 (p.R282W). Pertinent family history included a mother who suffered from leukemia. Therefore, given the patient's medical and family history, we consider this is a case of Li-Fraumeni syndrome associated with glioblastoma. The ethics approval is not applied since the case was in consultation with experts arranged through meeting organizer.","PeriodicalId":12731,"journal":{"name":"Glioma","volume":"3 1","pages":"71 - 75"},"PeriodicalIF":0.0000,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Glioma","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/glioma.glioma_17_20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Li-Fraumeni syndrome is an autosomal dominant cancer predisposition syndrome caused by germ line alterations in the tumor suppressor gene TP53, with an incidence of 1 in 5000–1 in 20,000. Li-Fraumeni syndrome is associated with numerous malignancies, including astrocytoma. Here, we report the case of a female patient diagnosed with glioblastoma in the right temporal lobe at the age of 22 years. She was treated with surgery followed by radiation and chemotherapy and achieved a complete response. Not surprisingly, the patient relapsed 7 years later and underwent a second surgery and radiation concurrent with temozolomide followed by chemotherapy with various agents. The patient currently remains tumor-free. Genetic testing revealed that the tumor contained a germ line mutation of TP53 (p.R282W). Pertinent family history included a mother who suffered from leukemia. Therefore, given the patient's medical and family history, we consider this is a case of Li-Fraumeni syndrome associated with glioblastoma. The ethics approval is not applied since the case was in consultation with experts arranged through meeting organizer.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一例年轻成人李-弗劳梅尼综合征相关胶质母细胞瘤患者:病例讨论和文献复习
Li-Fraumeni综合征是一种常染色体显性遗传癌症易感性综合征,由肿瘤抑制基因TP53的种系改变引起,发病率为1/5000–1/2000。李·弗劳梅尼综合征与许多恶性肿瘤有关,包括星形细胞瘤。在此,我们报告了一例女性患者,22岁时被诊断为右颞叶胶质母细胞瘤。她接受了手术治疗,随后进行了放疗和化疗,并取得了完全缓解。毫不奇怪,该患者在7年后复发,并接受了第二次手术和替莫唑胺放疗,然后用各种药物进行化疗。患者目前没有肿瘤。基因检测显示,该肿瘤含有TP53的种系突变(第R282W页)。相关家族史包括一位患有白血病的母亲。因此,鉴于患者的病史和家族史,我们认为这是一例与胶质母细胞瘤相关的李·弗劳梅尼综合征。由于该案件是通过会议组织者安排的专家咨询的,因此未申请伦理批准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
12
审稿时长
42 weeks
期刊最新文献
Molecular landscape of glucose metabolism in glioblastoma and the normal human brain: A narrative review Survival trends for patients with primary brain tumors worldwide: What have we learnt? Research progress in the treatment of glioblastoma by an oncolytic virus: A narrative review Current status of clinical application of immunotherapy in the treatment of glioma: A narrative review Scarring, without regeneration, is the therapeutic challenge for making palliative glioma treatments curative
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1